Related Experiment Videos
Cystic fibrosis: infection
1State Seruminstitute and University of Copenhagen, Department of Clinical Microbiology, Rigshospitalet.
Abstract:
Recurrent and chronic pulmonary infection is still the major cause of morbidity and mortality in cystic fibrosis. Although respiratory viruses are responsible for some of the acute exacerbations of the pulmonary disease, bacteria, and in some patients Aspergillus fumigatus, are the most important pathogens. Staphylococcus aureus and Haemophilus influenzae are the most prevalent pathogens in cystic fibrosis of childhood, whereas Pseudomonas aeruginosa and in some centres also Pseudomonas cepacia predominate in older children and adult patients. The chronic Pseudomonas aeruginosa infection is peculiar, since it is predominantly an endobronchial infection in small bronchioles caused by mucoid, alginate producing strains which gradually lose most of the O-antigenic determinants of the lipopolysaccharide. Although P. aeruginosa produces a number of other toxins which may play a role initially, most if not all of the pathology is caused by immune complex mediated chronic inflammation. The bacteriological results of antipseudomonas chemotherapy are disappointing, as these bacteria are virtually never permanently eliminated. The clinical results of repeated maintenance chemotherapy every 3 months are, however, good, since it is possible to preserve lung function for years and keep the patients alive. Antiinflammatory treatment with steroids for years is used in some patients with benefit.
Insights
Chronic pulmonary infections significantly impact cystic fibrosis patients. While bacteria like Pseudomonas aeruginosa are key pathogens, repeated chemotherapy preserves lung function and prolongs life.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Cystic Fibrosis Research
Background:
- Recurrent pulmonary infections are a primary cause of morbidity and mortality in cystic fibrosis.
- Key pathogens include Staphylococcus aureus, Haemophilus influenzae, and Pseudomonas aeruginosa, with the latter predominating in older patients.
- Chronic Pseudomonas aeruginosa infections are endobronchial, involving mucoid strains and leading to immune complex-mediated inflammation.
Purpose of the Study:
- To review the challenges and outcomes of managing chronic pulmonary infections in cystic fibrosis.
- To evaluate the efficacy of different therapeutic strategies against key bacterial pathogens.
Main Methods:
- Literature review of pathogens and treatment outcomes in cystic fibrosis pulmonary infections.
- Analysis of the characteristics of chronic Pseudomonas aeruginosa infection and its pathological mechanisms.
- Assessment of chemotherapy and anti-inflammatory treatment effectiveness.
Main Results:
- Bacteriological eradication of Pseudomonas aeruginosa is rarely achieved with chemotherapy.
- Repeated maintenance chemotherapy every 3 months demonstrates good clinical results, preserving lung function and improving survival.
- Anti-inflammatory treatment, including steroids, has shown benefit in some patients.
Conclusions:
- Pseudomonas aeruginosa remains a critical pathogen in cystic fibrosis, with chronic infection leading to significant inflammation.
- While complete eradication is difficult, consistent maintenance chemotherapy is vital for managing lung function and survival.
- Further research into effective anti-inflammatory and anti-pseudomonal strategies is warranted.